BMS-986353
CA061-1005
Phase 3 small_molecule active
Quick answer
BMS-986353 for Systemic Sclerosis is a Phase 3 program (small_molecule) at Bristol-Myers Squibb Australia Pty Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Bristol-Myers Squibb Australia Pty Ltd
- Indication
- Systemic Sclerosis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active